SCHEMBL23360378

SCHEMBL23360378

CC(C)(C)OC(=O)N1CCC(Nc2cccc3ncc(C(F)(F)F)cc23)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.54
SYK P43405 1/20 0.49
ALDH1A1 P00352 2/20 0.48
MAPT P10636 2/20 0.48
NPC1 O15118 1/20 0.48
MAPK1 P28482 1/20 0.48
HTT P42858 1/20 0.48
RAB9A P51151 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
MET P08581 1/20 0.47
IDH1 O75874 1/20 0.46
IDH2 P48735 1/20 0.46
JAK3 P52333 1/20 0.46
PTK2 Q05397 1/20 0.46
GPR119 Q8TDV5 3/20 0.46
TGFBR1 P36897 1/20 0.45
PIK3CA P42336 1/20 0.45
BRD4 O60885 1/20 0.44
IRAK4 Q9NWZ3 1/20 0.44
STS P08842 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23360335 0.89 CNR1 (0.51) CNR1ALDH1A1MAPTNPC1MAPK1
SCHEMBL23360355 0.87 CNR1 (0.58) CNR1ALDH1A1MAPTNPC1MAPK1
SCHEMBL23360493 0.86 ALDH1A1 (0.57) CNR1ALDH1A1MAPTNPC1MAPK1
SCHEMBL29862695 0.83 PIK3CD (0.51) CNR1IDH1PIK3CABRD4
SCHEMBL28834077 0.83 PIK3CD (0.51) CNR1IDH1PIK3CABRD4
SCHEMBL28834076 0.83 PIK3CD (0.51) CNR1IDH1PIK3CABRD4
SCHEMBL29862916 0.83 PIK3CD (0.51) CNR1IDH1PIK3CABRD4
SCHEMBL28834176 0.83 PIK3CD (0.51) CNR1IDH1PIK3CABRD4
SCHEMBL23360307 0.82 ALDH1A1 (0.51) CNR1ALDH1A1MAPTNPC1MAPK1
SCHEMBL28834295 0.82 PIK3CD (0.51) CNR1MAPTGPR119PIK3CABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4055014-B1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORP (KR) 2025-04-30 EP disclosed
CN-114867719-B Pyrrolidine and piperidine compounds 柳韩洋行 2024-06-25 CN disclosed
US-11655235-B2 Pyrrolidine and piperidine compounds YUHAN CORPORATION (KR) 2023-05-23 US disclosed
EP-4055014-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS Yuhan Corporation (KR) 2022-09-14 EP disclosed
CN-114867719-A Pyrrolidine and piperidine compounds 柳韩洋行 2022-08-05 CN disclosed
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORPORATION (KR) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11655235-B2 Pyrrolidine and piperidine compounds FAP, APC, VHL CNR1 3970/4885SYK 1594/4885ALDH1A1 439/4885
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS FAP, APC, VHL CNR1 3970/4885SYK 1594/4885ALDH1A1 439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.